孕酮市場規模、佔有率和成長分析：按劑型、給藥途徑、應用、藥物類型、分銷管道和地區分類－2026-2033年產業預測

2024 年全球黃體素市場價值為 16.3 億美元，預計到 2025 年將成長至 18.4 億美元，到 2033 年將成長至 47.9 億美元，在預測期（2026-2033 年）內複合年成長率為 12.74%。

全球孕酮市場正經歷顯著的變革，其主要驅動力是日益普遍的不孕症和荷爾蒙失調。隨著醫療專業人員將孕酮的應用範圍拓展到傳統產科用途之外，口服和注射用孕酮製劑的需求激增。更年期荷爾蒙補充療法和輔助生殖技術也進一步推動了市場成長。儘管美國仍然是主要的收入來源，但新興市場，尤其是印度，由於人們對生育治療的認知不斷提高，正經歷顯著的成長。監管政策的進步促使皮下注射和緩釋植入劑等創新給藥方式的出現，從而提高了患者的依從性。保險公司的支持正在拓展治療選擇，而製藥企業和生技公司在經皮吸收貼片研發方面的合作，正在加速成熟市場和新興市場的成長潛力。

全球孕酮市場成長要素

孕酮需求的成長主要源自於其在輔助生殖治療中應用的廣泛。這是因為孕酮在維持黃體期和穩定早期懷孕方面發揮著至關重要的作用。因此，孕酮處方量激增，尤其是在接受輔助生殖技術治療的患者以及尋求自然受孕支持的患者中。醫療專業人員依賴孕酮來提高胚胎著床成功率，而孕酮的使用也越來越被尋求輔助生殖治療的患者所接受。這種日益成長的需求不僅擴大了市場規模，也推動了新產品和給藥系統的研發，進而促使人們持續投資於研發，以最佳化劑型並提高患者的用藥依從性。

全球孕酮市場的限制因素

全球孕酮市場面臨諸多限制因素，其中最主要的限制因素是嚴格的法規核准流程，阻礙了市場成長。這些嚴格的要求導致研發週期延長，並要求對每種製劑的安全性和有效性進行全面詳盡的文件記錄。製造商在設計複雜的臨床試驗以及證明不同給藥方式下生物利用度的一致性方面面臨許多挑戰，導致產品上市延遲。這種對嚴格合規性的關注分散了創新資源，並常常阻礙中小企業進入市場。因此，更嚴格的監管要求抑制了市場動態，並縮小了消費者可選擇的治療方案範圍。

全球黃體素市場趨勢

受婦科健康解決方案需求成長的推動，全球孕酮市場呈現顯著上升趨勢。隨著月經紊亂、不孕症和更年期症狀的發生率增加，醫療專業人員越來越認可孕酮作為天然治療選擇。這種重視天然荷爾蒙平衡的趨勢，得益於病患教育工作的開展，這些工作旨在推廣生物同源激素的益處，從而提高了病患和醫療服務提供者對黃體素的接受度。因此，口服和注射孕酮製劑的市場正在擴張，預計在全球成熟市場和新興市場都將強勁成長。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球孕酮市場規模：以劑型分類。

• 天然孕酮
• 合成黃體素

全球孕酮市場規模：依給藥途徑分類

• 注射藥物
• 口服
• 外用/陰道用
• 經皮

全球孕酮市場規模：依應用分類

• 更年期管理
• 不孕症治療/體外受精（IVF）
• 子宮內膜異位症
• 異常子宮出血
• 預防早產

全球孕酮市場規模：依藥物類型分類

• 品牌
• 非專利的

全球孕酮市場規模：按分銷管道分類

• 醫院藥房
• 零售藥房
• 網路藥房

全球孕酮市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• IBSA Farmaceutici
• Besins Healthcare
• AbbVie Inc.
• Ferring Pharmaceuticals
• Merck & Co. Inc.
• Bayer AG
• Orion Pharma
• Pfizer Inc.
• Sun Pharmaceutical Industries
• Teva Pharmaceutical Industries
• Watson Pharmaceuticals（Allergan）
• Actavis（AbbVie）
• ANI Pharmaceuticals
• Laboratoire Theramex
• CooperSurgical
• Organon & Co.
• Medicis Pharma
• Athenex Inc.
• AMCO-PHOS
• Ivagen Pharma

結論與建議

Global Progesterone Market size was valued at USD 1.63 Billion in 2024 and is poised to grow from USD 1.84 Billion in 2025 to USD 4.79 Billion by 2033, growing at a CAGR of 12.74% during the forecast period (2026-2033).

The global progesterone market has evolved significantly, propelled by rising infertility rates and hormonal disorders. Demand for oral micronized and injectable progesterone formulations has surged as practitioners expand beyond traditional obstetric applications. Menopausal hormone replacement therapies and assisted reproductive technologies have further catalyzed market growth. The U.S. remains a key revenue contributor, while emerging markets, particularly India, are experiencing notable expansion due to heightened awareness of fertility treatments. Regulatory advancements have paved the way for innovative delivery methods, such as subcutaneous and sustained-release implant formulations, enhancing patient adherence. The support from insurance providers has broadened accessible treatment options, fostering collaboration between pharmaceutical manufacturers and biotech firms in developing transdermal patches, thereby unlocking growth potential in both established and developing markets.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Progesterone market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Progesterone Market Segments Analysis

Global progesterone market is segmented by formulation, route of administration, application, drug type, distribution channel and region. Based on formulation, the market is segmented into Natural Progesterone and Synthetic Progestins. Based on route of administration, the market is segmented into Injectables, Oral, Topical/Vaginal and Transdermal. Based on application, the market is segmented into Menopause Management, Fertility Treatment / IVF, Endometriosis, Abnormal Uterine Bleeding and Preterm Birth Prevention. Based on drug type, the market is segmented into Branded and Generic. Based on distribution channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Progesterone Market

The increasing demand for progesterone is significantly influenced by the growing utilization of fertility treatments, as it plays a crucial role in supporting the luteal phase and maintaining early pregnancy. This has led to a surge in prescription volumes, particularly within assisted reproductive technology cycles and for those seeking natural conception support. Healthcare professionals depend on progesterone to enhance implantation success rates, driving a wider acceptance among patients looking for fertility solutions. This increased dependence not only broadens the market's reach but also encourages the development of new products and delivery systems, thereby promoting ongoing investment in research to optimize dosage forms and improve patient adherence.

Restraints in the Global Progesterone Market

The global progesterone market faces significant restraints due to stringent regulatory approval processes that impede market growth. These stringent requirements lead to extended development timelines and necessitate comprehensive documentation of safety and efficacy for each formulation. Manufacturers are challenged by the need to navigate complex clinical trial designs and demonstrate consistent bioavailability across various delivery methods, resulting in delayed product launches. This rigorous compliance focus diverts resources away from innovation, often discouraging smaller companies from entering the market. As a result, the increased regulatory demands hinder market dynamics and limit the range of therapeutic options available to consumers.

Market Trends of the Global Progesterone Market

The global progesterone market is witnessing a significant upward trend driven by an increasing demand for gynecological health solutions. As the incidence of menstrual disorders, infertility, and menopausal symptoms rises, healthcare professionals are increasingly favoring progesterone as a natural therapeutic option. This shift towards prioritizing natural hormone balance is further bolstered by patient education initiatives that promote the advantages of bioidentical hormones, leading to greater acceptance among patients and providers alike. As a result, there is a growing market for both oral and injectable progesterone formulations, with robust expansion anticipated in both established and emerging regions worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Progesterone Market Size by Formulation & CAGR (2026-2033)

• Market Overview
• Natural Progesterone
• Synthetic Progestins

Global Progesterone Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Injectables
• Oral
• Topical/Vaginal
• Transdermal

Global Progesterone Market Size by Application & CAGR (2026-2033)

• Market Overview
• Menopause Management
• Fertility Treatment / IVF
• Endometriosis
• Abnormal Uterine Bleeding
• Preterm Birth Prevention

Global Progesterone Market Size by Drug Type & CAGR (2026-2033)

• Market Overview
• Branded
• Generic

Global Progesterone Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Progesterone Market Size & CAGR (2026-2033)

• North America (Formulation, Route of Administration, Application, Drug Type, Distribution Channel)
  • US
  • Canada
• Europe (Formulation, Route of Administration, Application, Drug Type, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Formulation, Route of Administration, Application, Drug Type, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Formulation, Route of Administration, Application, Drug Type, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Formulation, Route of Administration, Application, Drug Type, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• IBSA Farmaceutici
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Besins Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ferring Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co. Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orion Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Watson Pharmaceuticals (Allergan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Actavis (AbbVie)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ANI Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratoire Theramex
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CooperSurgical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Organon & Co.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medicis Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Athenex Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AMCO-PHOS
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ivagen Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations